Everett Cunningham - 21 Feb 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 Feb 2024, 20:00:24 UTC
Prior SEC filing
13 Oct 2023
Next SEC filing
28 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Everett Cunningham by Mark R. Busch, attorney-in-fact

Key filing fact

Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 23 Feb 2024.

Key facts

  • This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 23 Feb 2024, 20:00.

Change

  • Previous filing in this sequence was filed on 13 Oct 2023.
  • Current net transaction value: -$80,703.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXAS transaction

Common Stock

Award

Transaction value
$0
Shares
+2,711
Change %
+7.2%
Price
$0.000000
Shares after
40,620
Date
21 Feb 2024
Ownership
Direct
Footnotes
F1
EXAS transaction

Common Stock

Sale

Transaction value
$80,703
Shares
-1,350
Change %
-3.3%
Price
$59.78
Shares after
39,270
Date
22 Feb 2024
Ownership
Direct
Footnotes
F2, F3
EXAS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
571
Date
21 Feb 2024
Ownership
Held in 401(k) Plan
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024.

Footnote F2

Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.

Footnote F3

In addition to the shares of Common Stock reported on this Form 4, which total 39,841 shares, Mr. Cunningham also holds, in the aggregate, an additional 71,706 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .